Article
Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma
21 Oct 1993
Abstract excerpt
To investigate the role of the p53 tumor-suppressor gene in the development of human melanoma, loss of heterozygosity (LOH) of p53 was studied in 46 cases of melanoma by a polymerase-chain-reaction/restriction-fragment-length polymorphism (PCR/RFLP) analysis, and p53 mutations were assessed in 51 cases of melanoma by a polymerase-chain-reaction/single-strand-conformation polymorphism (PCR/SSCP) analysis. Frozen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
